for patients
with Urinary Urgency
Incontinence

Designed to provide

relief from UUI

If drugs are not the right solution for your UUI symptoms significantly, Neuspera’s integrated sacral neuromodulation (iSNM) system may be the solution for you. Neuspera’s (iSNM) system is designed to provide relief from the limiting effects of UUI with a clinically proven implantable device, utilizing an external battery that fits seamlessly into your daily life.

Outpatient Surgery
+
Outpatient Surgery

A smart, neurostimulator is implanted near the sacral nerve.

Activation
+
Activation

Therapy is activated using an external battery worn against the lower back daily.

External Battery
+
External Battery

Discrete external battery powers the implant.

Smartphone App
+
Smartphone App

Intuitive smart phone app for fast and easy adjustments to therapy.

our

offering

Simplified Experience

The Neuspera (iSNM) system provides relief of UUI symptoms while minimizing pain and discomfort of implanted batteries. Patients can benefit from an experience with the effective outcomes of proven sacral neuromodulation (SNM) therapy[1][2]. Our goal is to restore confidence, freedom and dignity so patients can focus on living their lives.

Our Technology

our technology &

sacral neuromodulation therapy

Effective Therapy

Sacral neuromodulation is a therapy that has been shown to reduce urgency incontinence by more than 50% in approximately 80% of patients. Individuals may experience even greater improvements with SNM in some cases. Neuspera’s integrated system provides patients a more flexible, clinically proven way of benefitting from sacral neuromodulation.[1][2]

Brain communicates back and forth to the bladder via signals from the sacral nerve up through the spine
Next-gen, integrated implant
Signals are sent from the brain to normalize bladder function
Energy is transferred to implant through electromagnetic waves
Implant sends electrical impulses to the sacral nerve which travel upwards to the brain

1 Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation. Steven Siegel,* Karen Noblett, Jeffrey Mangel, Jason Bennett,† Tomas L. Griebling, Suzette E. Sutherland, Erin T. Bird, Craig Comiter, Daniel Culkin, Samuel Zylstra, Fangyu Kan† and Kellie Chase Berg†

2 Neuromodulation in Overactive Bladder: A review and current perspectives. Troy Sukhu, Michael J Kennelly, and Raj Kurpad